Study of ASTX029 in Subjects With Advanced Solid Tumors

NCT03520075 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

192

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor, Adult

Interventions

DRUG: ASTX029
DRUG: ASTX029

Sponsor

Taiho Oncology, Inc.